Fore Biotherapeutics
A precision oncology company rooted in science and innovation, pioneering the development of unique cancer therapies.
$67.4M Series B+ ·
Led by SR One · Source: Pulse 2.0
Total raised: $182.4M across 3 sourced rounds
All 3 rounds ↓Signals
X account@ForeBiotx · created Feb 20, 2021 (5 years old) · 90 followers
Website registeredFeb 12, 2021 (5 years old)
TIMELINE · MONEY RAISED
Fore Biotherapeutics | 922 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $67.4M | Pulse 2.0 | ||
| Series B+ | $40M | — | startupintros.com | |
| Series B+ | $75M | jewishbusinessnews.com |
Timeline
- X account created
- Website created
Founders and team
GM
Giovanni Mariggi Co-founder and Partner at Medicxisource: fore.bioHG
Haim Gil-ad FounderMR
Matthew Ros FounderWR
William R. Hinshaw CEOGT
Gabi Tarcic Chief Technology OfficerMB
Michael Byrnes CFOMV
Michael Vidne Chief Business & Strategy OfficerSS
Stacie Shepherd CMO
Investors
33B Future Health Fund
AAxil Capital
CCormorant Asset Management
HHBM Healthcare Investments
HHBM PartnersLLG Technology Ventures
MMedicxilead investor
NNovartis Venture Fund
OOrbiMed
PPrimer Ventures
SSamsung Securities
SSR Onelead investor
SSymBiosis
- TTaiAx
WWellington Management
WWindham Venture Partners
Companies like Fore Biotherapeutics
FFrontier MedicinesSeries B+ · Aug 2025
MMariana Oncology$175M Series B+ · Sep 2023
SStarlight TherapeuticsSeed · Apr 2026
BBIOMAKERSSeries A · Jul 2026AAccent Therapeutics$75M Series B+ · Jan 2024
FFoRx Therapeutics$50M Series A · Dec 2025
Other companies backed by SR One
DDren Bio$350M Series B+ · Oct 2026IImmutrin$86.45M Series A · Mar 2026
CCorxel$287M Series B+ · Jan 2026AAirNexis Therapeutics$200M Series A · Jan 2026
AAddition Therapeutics$100M Series A · Dec 2025
PPulmocide$52M Series B+ · Dec 2022
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/fore-biotherapeutics (get a free API key).